DCF — ADVENTHEALTH SEBRING
Enterprise Value: $-171.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-171.6M
Enterprise Value
$-60.4M
PV of Cash Flows
$-111.2M
PV of Terminal Value
$-179.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $288.1M | $-7.4M | -3.0% | $-19.6M | $-17.8M |
| Year 2 | $296.7M | $-4.6M | -2.0% | $-17.2M | $-14.2M |
| Year 3 | $305.6M | $-1.7M | -1.0% | $-14.6M | $-11.0M |
| Year 4 | $314.8M | $-0.2M | -0.0% | $-13.5M | $-9.2M |
| Year 5 | $324.2M | $0.6M | 0.0% | $-13.1M | $-8.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-171.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$279.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03059900079905741
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5